Litigation Details for The Regents of the University of California v. Affymetrix, Inc. (S.D. Cal. 2017)
✉ Email this page to a colleague
The Regents of the University of California v. Affymetrix, Inc. (S.D. Cal. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-07-10 |
| Court | District Court, S.D. California | Date Terminated | 2019-04-09 |
| Cause | 35:0001 Establishment of PTO | Assigned To | |
| Jury Demand | Plaintiff | Referred To | |
| Parties | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | ||
| Patents | 7,038,085; 7,399,488 | ||
| Attorneys | Brendan Taber Jones | ||
| Firms | Latham and Watkins | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in The Regents of the University of California v. Affymetrix, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for The Regents of the University of California v. Affymetrix, Inc. (S.D. Cal. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-07-20 | 221 | Declaration of Timothy Swager, Ph.D. | Milnacipran, and Methods of use Thereof' U.S. Patent 7,038,085 (10/22/03) 13. Swager, T. M.; Yang, J.-S.….S. Patent No. 8,455,613 (the “’613 patent”), U.S. Patent No. 8,575,303 (the “’303 6 patent”), …, U.S. Patent No. 9,139,869 (the “’869 patent”), and U.S. Patent No. 7 9,547,008 (the “’008 patent…claims of the Sirigen patents. For 13 instance, claim 1 of the ’008 patent recites: “the polymer…cytometry. 17 ’613 patent, at 161:23-162:4 (emphasis added). The Sirigen patent specification 18 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
